Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | 7819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| Bisindolylmaleimide X hydrochloride；Ro31-8425 hydrochloride;BIM-X hydrochloride | C26H25ClN4O2 | 145317-11-9 | Details |
| BIBP3226 TFA | C29H32F3N5O5 | 1068148-47-9 | Details |
| BIBO3304 TFA | C31H36F3N7O5 | 191868-14-1 | Details |
| BI-749327 | C23H21F3N4O2 | 2361241-23-6 | Details |
| Tolbutamide | C12H18N2O3S | 64-77-7 | Details |
| Bithionol sulfoxide | C12H6Cl4O3S | 844-26-8 | Details |
| BIIL-260 hydrochloride | C30H31ClN2O3 | 192581-24-1 | Details |
| Bifeprunox | C24H23N3O2 | 350992-10-8 | Details |
| Bicyclomycin benzoate；FR2054 | C19H22N2O8 | 37134-40-0 | Details |
| Ifosfamide | C7H15Cl2N2O2P | 3778-73-2 | Details |
| BioE-1115 | C19H18FN3O2 | 1268863-35-9 | Details |
| Bitopertin (R enantiomer)；RG1678 (R enantiomer);RO4917838 (R enantiomer);Bitopertin R enantiomer | C21H20F7N3O4S | 845614-12-2 | Details |
| bio-THZ1 | C52H65ClN12O8S | 1604811-14-4 | Details |
| Biotin-VAD-FMK | C30H49FN6O8S | 1135688-15-1 | Details |
| Mebeverine hydrochloride | C25H35NO5.ClH | 2753-45-9 | Details |
| BF 227 | C16H16FN3O2S | 845647-80-5 | Details |
| BGB-102；JNJ-26483327 | C22H25BrN4O2 | 807640-87-5 | Details |
| ODM-207 | C22H21N3O3 | 1801503-93-4 | Details |
| Bexarotene D4；LGD1069 D4 | C24H24D4O2 | 2182068-00-2 | Details |
| BI 653048 | C23H25F4N3O4S | 1198784-72-3 | Details |
| BI 653048 phosphate | C23H28F4N3O8PS | 1198784-97-2 | Details |
| Proglumide | C18H26N2O4 | 6620-60-6 | Details |
| β3-AR agonist 1 | C22H28N4O4S | 1283125-73-4 | Details |
| I-BET282；BET-IN-1 | C25H30N4O4 | 1422554-34-4 | Details |
| BET-IN-2 | C23H29N3O | 2104688-91-5 | Details |
| β-NF-JQ1 | C45H42ClN5O6S | 2380000-55-3 | Details |
| BI-2852 | C31H28N6O2 | 2375482-51-0 | Details |
| Bisindolylmaleimide VIII acetate | C24H22N4O2 | 138516-31-1 | Details |
| BF-168 | C18H17FN2O2 | 634911-47-0 | Details |
| BMVC | C28H25IN3+ | 627810-06-4 | Details |
| BMT-145027 | C23H14ClF3N4 | 2018282-44-3 | Details |
| Fostemsavir Tris | C29H37N8O11P | 864953-39-9 | Details |
| Retinyl palmitate | C36H60O2 | 79-81-2 | Details |
| Bozitinib | C20H15F3N8 | 1440964-89-5 | Details |
| Carboplatin | C6H12N2O4Pt | 41575-94-4 | Details |
| BO3482 | C14H20N2NaO5S2 * | 198013-53-5 | Details |
| BMS-470539 dihydrochloride | C32H42ClN5O4 | 2341796-82-3 | Details |
| BMS-654457 | C36H37N5O4 | 1004551-41-0 | Details |
| BMS-1001 hydrochloride | C35H35ClN2O7 | 2113650-04-5 | Details |
| BMS-214662 | C25H23N5O2S2 | 195987-41-8 | Details |
| Azilsartan | C25H20N4O5 | 147403-03-0 | Details |
| Toltrazuril | C18H14F3N3O4S | 69004-03-1 | Details |
| BRD-IN-3 | C21H25N5O3 | 2351938-32-2 | Details |
| BRD-6929 | C19H17N3O2S | 849234-64-6 | Details |
| BJE6-106；B106 | C26H23NO2 | 1564249-38-2 | Details |
| BOC-D-FMK | C11H18FNO5 | 634911-80-1 | Details |
| Bixin | C25H30O4 | 6983-79-5 | Details |
| Borrelidin；Treponemycin | C28H43NO6 | 7184-60-3 | Details |
| BM 957 | C52H56ClF3N6O7S3 | 1391107-54-2 | Details |
| BPO-27 racemate | C26H18BrN3O6 | 1314873-02-3 | Details |
| Flumequine | C14H12FNO3 | 42835-25-6 | Details |
| BRCA1-IN-2 | C26H33N4O7P | 1622262-55-8 | Details |
| BRCA1-IN-1 | C27H33F2N4O6P | 1622262-74-1 | Details |
| BR351 precursor | C27H32N2O8S2 | 960113-89-7 | Details |
| BRAF inhibitor | C22H18F2N4O3S | 918505-61-0 | Details |
| BRD 4354 | C21H23ClN4O | 315698-07-8 | Details |
| BPH-1358 free base；NSC50460 free base | C32H28N6O2 | 801985-13-7 | Details |
| BR351 | C20H25FN2O5S | 960113-85-3 | Details |
| BRL44385 | C8H11N5O3 | 114778-60-8 | Details |
| Brevetoxin-3；PbTx-3 | C50H72O14 | 85079-48-7 | Details |
| Brexpiprazole-d8；OPC-34712 D8;Brexpiprazole D8 | C25H27N3O2S | 1427049-21-5 | Details |
| Brexpiprazole S-oxide；DM-3411 | C25H27N3O3S | 1191900-51-2 | Details |
| BLM-IN-1 | C28H35FN4O | 2056014-40-3 | Details |
| Isoprenaline hydrochloride | C11H18ClNO3 | 51-30-9 | Details |
| (8R,9S)-Talazoparib；(8R,9S)-BMN-673 | C19H14F2N6O | 1207456-00-5 | Details |
| BM635 | C25H29FN2O | 1493762-74-5 | Details |
| BM-131246 | C22H20N2O4S | 103787-97-9 | Details |
| (4-Acetamidocyclohexyl) nitrate；BM121307 | C8H14N2O4 | 137213-91-3 | Details |
| BMT-124110 | C21H27N3O3 | 1679371-59-5 | Details |
| BO-264 | C18H19N5O3 | 2408648-20-2 | Details |
| Brofaromine；CGP 11305A | C14H16BrNO2 | 63638-91-5 | Details |
| BMS-901715 | C22H28N10O | 1699861-37-4 | Details |
| BPH-652 | C16H16K3O7PS | 157124-84-0 | Details |
| BQ-788 sodium salt | C34H52N5NaO7 | 156161-89-6 | Details |
| bpV(phen) | C12H8N2O5V.K | 42494-73-5 | Details |
| BPR1M97 | C18H18Cl2N2O | 2059904-66-2 | Details |
| Bovinic acid | C18H32O2 | 2540-56-9 | Details |
| BKI-1369 | C23H27N7O | 1951431-22-3 | Details |
| BMS-191095 | C22H21ClN4O2 | 166095-21-2 | Details |
| BRM/BRG1 ATP Inhibitor-1 | C11H9F3N4O2S | 2270879-17-7 | Details |
| BR102375 | C31H34N6O4 | 2366255-59-4 | Details |
| BRD-K98645985 | C33H43N5O4 | 1357647-78-9 | Details |
| BRD5648 | C20H23N3O | 2056261-42-6 | Details |
| BRL 37344 sodium；BRL 37344A | C19H23ClNNaO4 | 127299-93-8 | Details |
| BPI-9016M | C25H18F2N4O3 | 1528546-94-2 | Details |
| BPN-15606 | C23H23FN6O | 1914989-49-3 | Details |
| BMY-43748 | C20H17F3N4O3 | 132195-65-4 | Details |
| BPH-1358 | C32H29ClN6O2 | 5352-53-4 | Details |
| BQ-788 | C34H51N5O7 | 173326-37-9 | Details |
| Zatolmilast | C21H15ClF3NO2 | 1606974-33-7 | Details |
| BI-9321 | C22H21FN4 | 2387510-86-1 | Details |
| β-Cryptoxanthin；(3R)-β-Cryptoxanthin | C40H56O | 472-70-8 | Details |
| BI-1408 | C22H23FN6 | 2231075-94-6 | Details |
| BIO-32546 | C28H31F6NO3 | 1548743-66-3 | Details |
| BRD0705 | C20H23N3O | 2056261-41-5 | Details |
| BMY-25271 | C12H19N5O2S2 | 78441-82-4 | Details |
| Betrixaban-d6；Betrixaban D6 | C23H22ClN5O3 | 2098655-51-5 | Details |
| BRL-42715 | C10H9N4NaO3S | 102209-75-6 | Details |
| BIX-01338 hydrate；BIX 01338 hydrate;BIX01338 hydrate | C32H26F3N3O7 | 1228184-65-3 | Details |
| BI-9321 trihydrochloride | C22H22ClFN4 | 2387510-87-2 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 | ||||